YOUNG DAVID (Chief Executive Officer) exercised options at PROCESSA PHARMACEUTICALS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 4/11/2025ACC: 0000897069-25-000787
DirectorOfficer· Chief Executive Officer
Since Oct 2020
+11.93K
Net shares
Net buyer
$2.2K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
17.27K acquired · 5.34K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+17.27K
Price / share
—
Trade value
—
% of position
8.4%
4/1/2025
205.41K→222.68K
Common Stock
Direct
Shares
−5.34K
Price / share
$0.41
Trade value
$2.20K
% of position
2.4%
4/1/2025
222.68K→217.33K
Total
Net shares
+11.93K
Net value
-$2.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/1/2025 | M · Option Exercise | +17.27K | — | — | 8.4% | 205.41K | 222.68K |
| Common Stock Direct | 4/1/2025 | F · Tax Withholding | −5.34K | $0.41 | $2.20K | 2.4% | 222.68K | 217.33K |
| Total | +11.93K | -$2.20K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned10.79K
Common Stock
IndirectShares owned30.98K
Common Stock
IndirectShares owned18.54K
Total
60.31K indirect60.31K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10.79K | Indirect |
| Common Stock | 30.98K | Indirect |
| Common Stock | 18.54K | Indirect |
| Total | 60.31K | 60.31K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported